Fantoni, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 5.356
EU - Europa 4.150
AS - Asia 4.028
SA - Sud America 810
AF - Africa 169
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 10
Totale 14.555
Nazione #
US - Stati Uniti d'America 5.130
SG - Singapore 1.810
IT - Italia 988
CN - Cina 796
DE - Germania 691
SE - Svezia 687
BR - Brasile 641
VN - Vietnam 446
FR - Francia 431
GB - Regno Unito 289
PL - Polonia 195
IE - Irlanda 182
IN - India 164
FI - Finlandia 134
HK - Hong Kong 131
CA - Canada 128
JP - Giappone 127
UA - Ucraina 120
ID - Indonesia 119
AT - Austria 97
RU - Federazione Russa 88
BD - Bangladesh 66
MX - Messico 60
NL - Olanda 60
IQ - Iraq 51
TR - Turchia 49
AR - Argentina 48
ZA - Sudafrica 45
BE - Belgio 37
SA - Arabia Saudita 34
KR - Corea 32
EC - Ecuador 29
AU - Australia 28
ES - Italia 28
PK - Pakistan 28
PH - Filippine 25
IR - Iran 23
MA - Marocco 22
CO - Colombia 21
VE - Venezuela 21
CH - Svizzera 20
PY - Paraguay 18
BG - Bulgaria 17
CI - Costa d'Avorio 15
EG - Egitto 15
CL - Cile 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
KE - Kenya 12
MY - Malesia 12
CZ - Repubblica Ceca 11
LT - Lituania 11
NP - Nepal 11
PT - Portogallo 11
UY - Uruguay 11
UZ - Uzbekistan 11
CR - Costa Rica 10
ET - Etiopia 10
IL - Israele 10
JO - Giordania 10
GR - Grecia 9
KZ - Kazakistan 9
AO - Angola 8
KG - Kirghizistan 8
DK - Danimarca 7
PA - Panama 7
DZ - Algeria 6
EU - Europa 6
HR - Croazia 6
NG - Nigeria 6
AL - Albania 5
BH - Bahrain 5
EE - Estonia 5
BO - Bolivia 4
JM - Giamaica 4
LV - Lettonia 4
OM - Oman 4
RO - Romania 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
LA - Repubblica Popolare Democratica del Laos 3
MO - Macao, regione amministrativa speciale della Cina 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PE - Perù 3
SD - Sudan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BY - Bielorussia 2
CM - Camerun 2
DJ - Gibuti 2
GE - Georgia 2
GT - Guatemala 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
MG - Madagascar 2
Totale 14.522
Città #
Singapore 1.006
Chandler 585
Ashburn 583
San Jose 576
New York 250
Rome 232
Dublin 173
Beijing 161
Ho Chi Minh City 155
Los Angeles 151
Milan 146
Warsaw 141
Dallas 134
Hanoi 124
Chicago 122
The Dalles 117
Hong Kong 105
Tokyo 105
Jakarta 101
San Mateo 99
Marseille 95
Jacksonville 92
Lauterbourg 92
Hefei 86
Frankfurt am Main 85
Ann Arbor 78
Boston 74
Helsinki 73
Council Bluffs 70
Wilmington 68
Munich 66
São Paulo 64
Vienna 63
Houston 59
Boardman 57
Princeton 54
Bremen 51
North Bergen 51
Nanjing 47
Nuremberg 47
Fairfield 46
St Louis 44
London 42
Moscow 42
Seattle 40
Cattolica 37
Dearborn 36
Montreal 36
Woodbridge 36
Buffalo 35
Kraków 33
Orem 32
Santa Clara 29
Brussels 28
Denver 28
Toronto 28
Johannesburg 27
Seoul 27
Stockholm 24
Chennai 23
Haiphong 23
Paris 23
Atlanta 22
Mexico City 22
Amsterdam 21
Brooklyn 21
Nanchang 21
Poplar 21
Rio de Janeiro 21
Augusta 20
Kent 20
Lawrence 20
Redwood City 20
Da Nang 19
Nürnberg 19
Baghdad 18
Pune 18
Turku 18
Casalecchio di Reno 17
Lappeenranta 17
Belo Horizonte 16
Dhaka 16
Düsseldorf 16
Quito 16
Shanghai 16
Shenyang 16
Washington 16
Abidjan 15
Dammam 15
Manchester 15
Norwalk 15
Zurich 15
Cambridge 14
Changsha 14
Ottawa 13
Phoenix 13
San Francisco 13
Tianjin 13
Mumbai 12
New Delhi 12
Totale 7.803
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 526
New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years 493
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 231
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 227
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 208
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 201
A real-time integrated framework to support clinical decision making for covid-19 patients 198
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 197
Post-operative spondylodiscitis. 192
Residual respiratory impairment after COVID-19 pneumonia 190
Malnutrition in COVID-19 survivors: prevalence and risk factors 190
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 189
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 189
Covid-19 seroprevalence among healthcare workers of a large covid-19 hospital in rome reveals strengths and limits of two different serological tests 189
Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome 181
Malnutrition in COVID-19 survivors: prevalence and risk factors 178
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 176
COVID-19 atypical Parsonage-Turner syndrome: a case report 174
A Machine Learning Predictive Model of Bloodstream Infection in Hospitalized Patients 174
Initial antifungal strategy does not correlate with mortality in patients with candidemia 174
Impact of antibiotic stewardship on perioperative antimicrobial prophylaxis 171
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 170
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 169
Is posterior percutaneous screw-rod instrumentation a safe and effective alternative approach to TLSO rigid bracing for single-level pyogenic spondylodiscitis? Results of a retrospective cohort analysis 168
Residual respiratory impairment after COVID-19 pneumonia 168
It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey 167
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 163
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study 157
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 156
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series 156
Early assessment of blood culture negativity as a potential support tool for antimicrobial stewardship 155
Candida utilis catheter-related bloodstream infection 155
Sarilumab use in severe SARS-CoV-2 pneumonia 155
Medical and surgical treatment of pyogenic spondylodiscitis. 153
Pan-echinocandin-resistant candida glabrata bloodstream infection complicating covid-19: A fatal case report 150
Procalcitonin is useful in driving the choice of early antibiotic treatment in patients with bloodstream infections 147
Antibiotic appropriateness and adherence to local guidelines in perioperative prophylaxis: results from an antimicrobial stewardship intervention 140
Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital 139
A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections 138
Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes 138
Performance evaluation of the (1,3)-β-D-glucan detection assay in non-intensive care unit adult patients 138
First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii 137
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 136
Postmortem Swabs in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic 136
Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model? 135
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection 135
Epidemiological and clinical features of pyogenic spondylodiscitis. 133
Challenges in COVID-19: is pulmonary thromboembolism related to overall severity? 133
Prognostic role of serum procalcitonin measurement in adult patients admitted to the emergency department with fever 133
Idsa Did Not Endorse the Surviving Sepsis Campaign Guidelines 132
Post-prescription audit plus beta-d-glucan assessment decrease echinocandin use in people with suspected invasive candidiasis 132
Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients 131
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 128
Systemic Inflammation Response Index (SIRI) and Monocyte-to-Lymphocyte Ratio (MLR) Are Predictors of Good Outcomes in Surgical Treatment of Periprosthetic Joint Infections of Lower Limbs: A Single-Center Retrospective Analysis 127
Challenges in COVID-19: is pulmonary thromboembolism related to overall severity? 127
Short-term adverse effects from and discontiuation of antiretroviral post-exposure prophylaxis 125
Pyogenic and Tubercular Spondylodiscitis - Editorial 125
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection 124
Social media as a tool for scientific updating at the time of COVID pandemic: Results from a national survey in Italy 123
Association between Older Age and Psychiatric Symptoms in a Population of Hospitalized Patients with COVID-19 122
Predictors of mortality among adult, old and the oldest old patients with bloodstream infections: An age comparison 121
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study 119
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 117
Hand hygiene, knowledge and training motivational drives: findings from a survey in a university hospital 115
Cefiderocol-containing regimens for the treatment of carbapenem-resistant A. baumannii ventilator-associated pneumonia: a propensity-weighted cohort study 115
Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy. 114
Association of Delirium and Depression with Respiratory and Outcome Measures in COVID-19 Inpatients 112
Cefiderocol for severe carbapenem-resistant a. Baumannii pneumonia: Towards the comprehension of its place in therapy 111
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 111
Systematic clinical management of patients with candidemia improves survival 110
Answer to the Letter to the Editor of S. Huang et al. concerning “New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years” by Enrico Pola et al. Eur Spine J (2017) doi:10.1007/s00586-017-5043-5 110
Initial antifungal strategy does not correlate with mortality in patients with candidemia 107
A proposal for a comprehensive approach to infections across the surgical pathway 106
Antibiotic stewardship from toolkit to local implementation: The 'gutta cavat lapidem' strategy 105
Epidemiological and clinical features of prosthetic joint infections caused by gram-negative bacteria 105
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 102
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 100
The role of procalcitonin outside of the Intensive Care Unit (ICU): A multidisciplinary approach 100
Cervicofacial actinomycosis: still a difficult differential diagnosis 99
Drugs and cardiotoxicity in HIV and AIDS 98
Myocardial Injury Portends a Higher Risk of Mortality and Long-Term Cardiovascular Sequelae after Hospital Discharge in COVID-19 Survivors 97
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 97
Minimally invasive surgery for the treatment of thoraco lumbar pyogenic spondylodiscitis: indications and outcomes. 97
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 94
Determinants of SARS-COV-2 seroconversion in a cohort of recovered patients 94
Prognostic role of serum procalcitonin measurement in adult patients admitted to the emergency department with fever 93
Use of procalcitonin as a tool for antibiotic stewardship 93
Two years later: Is the SARS-CoV-2 pandemic still having an impact on emergency surgery? An international cross-sectional survey among WSES members 88
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 87
Atypical isolated epiglottic tubercolosis: a case report and review of the literature 87
Nursing home residence is associated with spread of Clostridium difficile ribotype 027 in central Italy 86
Evaluation and management of metabolic and coagulative disorders in HIV-infected patients receiving highly active antiretroviral therapy. 84
Initial antifungal strategy does not correlate with mortality in patients with candidemia 83
A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria 82
Initial antifungal strategy does not correlate with mortality in patients with candidemia 81
Atypical isolated epiglottic tuberculosis: a case report and a review of the literature 81
Day 10 post-prescription audit optimizes antibiotic therapy in patients with bloodstream infections 80
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 73
The pavia consensus statement 72
Totale 14.262
Categoria #
all - tutte 60.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 0 89 18
2021/2022867 61 44 17 66 34 31 16 140 47 76 165 170
2022/20232.326 255 259 207 379 219 268 160 109 244 111 80 35
2023/20241.177 37 243 55 53 64 216 82 34 26 76 117 174
2024/20252.562 42 80 189 128 187 99 130 134 416 258 497 402
2025/20266.054 787 238 447 789 1.080 378 1.079 342 446 462 6 0
Totale 14.787